We are live on
!
Find out more
AG
Algert Global Portfolio holdings
AUM
$6.65B
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+10.54%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$350M
AUM Growth
+$3.84M
(+1.1%)
Cap. Flow
-$17.9M
Cap. Flow
% of AUM
-5.11%
Top 10 Holdings %
Top 10 Hldgs %
9.45%
Holding
451
New
91
Increased
146
Reduced
82
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$2.52M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$2.51M |
| 3 |
SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
|
+$2.42M |
| 4 |
TVPT
Travelport Worldwide Limited
TVPT
|
+$2.31M |
| 5 |
D.R. Horton
DHI
|
+$2.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$3.4M |
| 2 |
MASI
Masimo
MASI
|
+$3.21M |
| 3 |
PERY
Perry Ellis International Inc
PERY
|
+$2.89M |
| 4 |
Idexx Laboratories
IDXX
|
+$2.8M |
| 5 |
LCI Industries
LCII
|
+$2.36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.36% |
| 2 | Technology | 18.52% |
| 3 | Industrials | 18.25% |
| 4 | Healthcare | 12.21% |
| 5 | Communication Services | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Rigel Pharmaceuticals
RIGL
$727M
| $172K | 0.05% |
7,225
-26,141
| -78% | -$749K |
|
302
Lakeland Industries
LAKE
$113M
| $167K | 0.05% |
+16,037
| New | +$170K |
|
|
RTK
303
DELISTED
Rentech, Inc.
RTK
| $157K | 0.04% |
+63,105
| New | +$141K |
|
|
NCIT
304
DELISTED
NCI, Inc.
NCIT
| $153K | 0.04% |
10,975
-31,615
| -74% | -$399K |
|
305
Consumer Portfolio Services
CPSS
$195M
| $146K | 0.04% |
28,478
+17,014
| +148% | +$81.7K |
|
306
OFG Bancorp
OFG
$2.11B
| $145K | 0.04% |
11,093
+700
| +7% | +$8.41K |
|
|
EGIO
307
DELISTED
Edgio, Inc. Common Stock
EGIO
| $138K | 0.04% |
1,372
-5,632
| -80% | -$478K |
|
|
STRR
308
DELISTED
Star Equity Holdings
STRR
| $137K | 0.04% |
550
| – | – |
|
309
Ultralife
ULBI
$87.8M
| $135K | 0.04% |
27,174
| – | – |
|
|
IO
310
DELISTED
ION Geophysical Corporation
IO
| $135K | 0.04% |
+22,579
| New | +$155K |
|
311
Orion Group Holdings
ORN
$513M
| $123K | 0.04% |
+12,320
| New | +$110K |
|
|
ARQL
312
DELISTED
Arqule Inc
ARQL
| $121K | 0.03% |
95,769
-25,523
| -21% | -$35.6K |
|
313
Vera Bradley
VRA
$106M
| $118K | 0.03% |
10,067
| – | – |
|
314
Costamare
CMRE
$1.8B
| $117K | 0.03% |
20,904
-15,110
| -42% | -$100K |
|
|
ARRY
315
DELISTED
Array Biopharma Inc
ARRY
| $113K | 0.03% |
12,802
| – | – |
|
|
PFNX
316
DELISTED
Pfenex Inc.
PFNX
| $102K | 0.03% |
+11,259
| New | +$103K |
|
|
ARTX
317
DELISTED
Arotech Corporation
ARTX
| $72K | 0.02% |
+20,650
| New | +$68.7K |
|
318
Quantum Corp
QMCO
$433M
| $66K | 0.02% |
+495
| New | +$64.8K |
|
|
DZSI
319
DELISTED
DZS Inc. Common Stock
DZSI
| $59K | 0.02% |
12,089
-39,874
| -77% | -$210K |
|
|
ODP
320
DELISTED
ODP
ODP
| $58K | 0.02% |
+1,283
| New | +$53.1K |
|
321
Ameresco
AMRC
$1.22B
| $56K | 0.02% |
+10,179
| New | +$56.6K |
|
322
Pixelworks
PXLW
$35.6M
| $56K | 0.02% |
+1,659
| New | +$56.2K |
|
323
Electromed
ELMD
$338M
| $44K | 0.01% |
+11,310
| New | +$46.7K |
|
|
CMLS
324
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $25K | 0.01% |
+24,420
| New | +$35.7K |
|
|
PTX
325
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $24K | 0.01% |
+12,570
| New | +$45.5K |
|
Similar funds
TB
CI
MIP
AS
NMIMC
AACR
MSE
FLPIM
Algert Global's Q4 2016 Portfolio in Review
As of Q4 2016, Algert Global held 451 positions worth $350M, up 1.1% from $346M the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Algert Global withdrew a net $17.9M in Q4 2016, closing 126 positions and reducing 82 holdings. Its most notable exit was Masimo, an estimated $3.21M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.
Against the trend, Algert Global opened a new position in MALLINCKRODT PUBLIC LIMITED COMPANY worth $2.13M.
- Algert Global's largest Q4 2016 buy was MALLINCKRODT PUBLIC LIMITED COMPANY: 42,706 shares worth $2.13M.
- Algert Global added most to Hologic in Q4 2016, an estimated $2.16M increase.
- Algert Global's biggest Q4 2016 reduction was KLA, cutting an estimated $3.4M.
- Algert Global fully exited Masimo in Q4 2016, selling an estimated $3.21M.
- Algert Global's ten largest holdings make up 9.4% of its $350M portfolio in Q4 2016.
- Algert Global opened 91 new positions and closed 126 in Q4 2016.
- Algert Global's portfolio value rose 1.1% quarter-over-quarter to $350M.
Based on Algert Global's 13F filing for Q4 2016, filed 26 Jan 2017.